Share on Pinterest‘Nissle did not kill pathogenic E. coli but rather ramps up your intestinal responses and prepares you for possible pathogens attacking the intestine,’ says the lead author of the new study.Most strains of the bacterium E. coli are benign, but some can cause severe illness, including stomach cramps, vomiting, and diarrhea. The bacteria…
Share on PinterestNew research highlights the importance of certain probiotic bacteria for the health of the upper respiratory tract.“Friendly bacteria” from the genus Lactobacillus are known to have beneficial effects in the gut, genital tract, and skin, where they protect against infection and modify immune responses. Lactobacilli are rod-shaped bacteria that ferment sugar, producing lactic…
You don't have permission to access "http://www.medpagetoday.com/meetingcoverage/sabcs/119005" on this server. Reference #18.ac2d3e17.1765724542.59e5bdbf https://errors.edgesuite.net/18.ac2d3e17.1765724542.59e5bdbf
3 min read This story is part of a series on 10 life-saving medical breakthroughs. Click here to read the rest. ANTONIO TORRES, A 24-year-old from Denver, used to spend six hours each day bathing and meticulously wrapping the red, raw skin along his shoulders and spine. “My wounds take up a large percentage of
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use has recommended granting marketing authorization for Moderna’s new RNA-based vaccine, mNexspike, for preventing COVID-19 in people aged 12 years or older. The vaccine was approved in May 2025 by the US FDA for individuals aged 65 years or older or aged 12-64 years